NRT Smoking Cessation Aids in Japan

NRT Smoking Cessation Aids in Japan

  • November 2016
  • 24 pages
  • Euromonitor International
Report ID: 150149
Thanks to increasing health awareness, the number of smokers in Japan continued to decline in 2016. According to research from the leading tobacco manufacturer, Japan Tobacco, in May 2016, male smoking prevalence fell to below 30% for the first time in 40 years, down 0.6 percentage points on the previous year. Many consumers are finding healthier ways to deal with stress, such as through jogging or yoga. Moreover, more male consumers have become more conscious about their appearance, with smokin...

Euromonitor International’s NRT Smoking Cessation Aids in Japan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2011-2015, allowing you to identify the sectors driving growth. Forecasts to 2020 illustrate how the market is set to change.

Product coverage: NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the NRT Smoking Cessation Aids market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

NRT SMOKING CESSATION AIDS IN JAPAN
Euromonitor International
November 2016

LIST OF CONTENTS AND TABLES

Headlines
Trends
Competitive Landscape
Prospects
Category Indicators
Table 1 Number of Smokers by Gender 2011-2016
Category Data
Table 2 Sales of NRT Smoking Cessation Aids by Category: Value 2011-2016
Table 3 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2011-2016
Table 4 Sales of NRT Gum by Flavour: % Value 2011-2016
Table 5 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2012-2016
Table 6 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2013-2016
Table 7 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2016-2021
Table 8 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2016-2021
Takeda Pharmaceutical Co Ltd in Consumer Health (japan)
Strategic Direction
Key Facts
Summary 1 Takeda Pharmaceutical Co Ltd: Key Facts
Summary 2 Takeda Pharmaceutical Co Ltd: Operational Indicators
Competitive Positioning
Summary 3 Takeda Pharmaceutical Co Ltd: Competitive Position 2016
Executive Summary
Consumer Health Industry Benefits From the Growing Self-medication Trend
Sales Also Boosted by Demand From Inbound Tourists
Competitive Environment Remains Fragmented
Drugstores/parapharmacies Gain Share
Further Positive Growth Expected Over the Forecast Period
Key Trends and Developments
Self-medication Continues To Increase
Channels
Inbound Tourism Boosts Demand
Market Indicators
Table 9 Consumer Expenditure on Health Goods and Medical Services: Value 2011-2016
Table 10 Life Expectancy at Birth 2011-2016
Market Data
Table 11 Sales of Consumer Health by Category: Value 2011-2016
Table 12 Sales of Consumer Health by Category: % Value Growth 2011-2016
Table 13 NBO Company Shares of Consumer Health: % Value 2012-2016
Table 14 LBN Brand Shares of Consumer Health: % Value 2013-2016
Table 15 Penetration of Private Label in Consumer Health by Category: % Value 2011-2016
Table 16 Distribution of Consumer Health by Format: % Value 2011-2016
Table 17 Distribution of Consumer Health by Format and Category: % Value 2016
Table 18 Forecast Sales of Consumer Health by Category: Value 2016-2021
Table 19 Forecast Sales of Consumer Health by Category: % Value Growth 2016-2021
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Summary 4 OTC: Switches 2014-2016
Sources
Summary 5 Research Sources












Loading...

We are very sorry, but an error occurred.
Please contact support@reportbuyer.com if the problem remains.

Country=Japan Industry=OTC ParentIndustry=Pharmaceutical Date=201611 Topic=MarketReport Publisher=EuromonitorInternational Price=1000